文摘
The discovery and scale-up of two routes to sampatrilat aredescribed. The first Chemical R and D route used a side productfrom another development project to accelerate drug supplyand expedite the early development programme. The second,more efficient Chemical R and D route had the potential forcommercialisation and used an environmentally friendly variantof the Baylis-Hillman reaction, and an asymmetric Michaeladdition as key steps. Full preparative details for the aminomethacrylate 4, a potentially useful chiral synthon, are givenfor the first time, along with full experimental details of theasymmetric Michael addition to make the chiral glutarate 5.Finally, a striking polymorph case history is described.